Literature DB >> 12900806

Leukocytosis, hypoalbuminemia, and the risk for chronic kidney disease in US adults.

Thomas P Erlinger1, Michelle E Tarver-Carr, Neil R Powe, Lawrence J Appel, Josef Coresh, Mark S Eberhardt, Frederick L Brancati.   

Abstract

BACKGROUND: Atherosclerosis and chronic kidney disease (CKD) share several common antecedents. However, the association between inflammatory markers and incident CKD is unknown.
METHODS: We determined risk for incident CKD, defined by treatment for kidney failure or death related to kidney disease, in 9,250 US adults aged 30 to 74 years who participated in the Second National Health and Nutrition Examination Survey (NHANES II), a nationally representative prospective cohort study with 17 years of follow-up.
RESULTS: After adjusting for age, race, sex, blood pressure, smoking, and body mass index, there was a graded positive association with increasing total white blood cell (WBC) count and risk for CKD (P for trend < 0.001; relative hazard (RH) highest versus lowest quartile, 2.34; 95% confidence interval [CI], 1.30 to 4.19). This association remained statistically significant after adjusting further for the presence of diabetes and cardiovascular disease at baseline (RH, 2.01; 95% CI, 1.11 to 3.65). A similarly strong and graded association with incident CKD was observed for hypoalbuminemia after adjusting for age, race, sex, blood pressure, smoking, and body mass index (P for trend = 0.02; RH lowest versus highest quartile, 1.91; 95% CI, 0.89 to 4.07) and additionally adjusting for the presence of diabetes and cardiovascular disease at baseline (P for trend = 0.02; RH lowest versus highest, 2.05; 95% CI, 0.96 to 4.39).
CONCLUSION: In a nationally representative sample of US adults, elevated WBC count and hypoalbuminemia were associated with future risk for CKD. These results support the hypothesis that systemic inflammation is an independent risk factor for CKD.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12900806     DOI: 10.1016/s0272-6386(03)00650-4

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN: 0272-6386            Impact factor:   8.860


  24 in total

1.  Risk factors for end-stage renal disease: 25-year follow-up.

Authors:  Chi-yuan Hsu; Carlos Iribarren; Charles E McCulloch; Jeanne Darbinian; Alan S Go
Journal:  Arch Intern Med       Date:  2009-02-23

Review 2.  Statins, inflammation and kidney disease.

Authors:  Vera Krane; Christoph Wanner
Journal:  Nat Rev Nephrol       Date:  2011-05-31       Impact factor: 28.314

3.  Association between circulating specific leukocyte types and incident chronic kidney disease: the Atherosclerosis Risk in Communities (ARIC) study.

Authors:  Niu Tian; Alan D Penman; R Davis Manning; Michael F Flessner; Anthony R Mawson
Journal:  J Am Soc Hypertens       Date:  2011-11-03

4.  Markers of inflammation predict the long-term risk of developing chronic kidney disease: a population-based cohort study.

Authors:  Anoop Shankar; Liping Sun; Barbara E K Klein; Kristine E Lee; Paul Muntner; F Javier Nieto; Michael Y Tsai; Karen J Cruickshanks; Carla R Schubert; Peter C Brazy; Josef Coresh; Ronald Klein
Journal:  Kidney Int       Date:  2011-08-24       Impact factor: 10.612

5.  Luteinizing hormone signaling restricts hematopoietic stem cell expansion during puberty.

Authors:  Yi Jacky Peng; Hua Yu; Xiaoxin Hao; Wenjie Dong; Xiujuan Yin; Minghui Lin; Junke Zheng; Bo O Zhou
Journal:  EMBO J       Date:  2018-07-23       Impact factor: 11.598

6.  Serum Potassium, End-Stage Renal Disease and Mortality in Chronic Kidney Disease.

Authors:  Georges N Nakhoul; Haiquan Huang; Susana Arrigain; Stacey E Jolly; Jesse D Schold; Joseph V Nally; Sankar D Navaneethan
Journal:  Am J Nephrol       Date:  2015-07-25       Impact factor: 3.754

7.  Does inflammation fuel the fire in CKD?

Authors:  Dena E Rifkin; Mark J Sarnak
Journal:  Am J Kidney Dis       Date:  2009-04       Impact factor: 8.860

8.  Genetic and environmental influences on the associations between change in kidney function and changes in cardiometabolic factors in Koreans.

Authors:  Yun-Mi Song; Joohon Sung; Kayoung Lee
Journal:  Clin Exp Nephrol       Date:  2016-06-23       Impact factor: 2.801

9.  Inflammation, hemostasis, and the risk of kidney function decline in the Atherosclerosis Risk in Communities (ARIC) Study.

Authors:  Lori D Bash; Thomas P Erlinger; Josef Coresh; Jane Marsh-Manzi; Aaron R Folsom; Brad C Astor
Journal:  Am J Kidney Dis       Date:  2008-12-24       Impact factor: 8.860

10.  Association of hsCRP, white blood cell count and ferritin with renal outcome in chronic kidney disease patients.

Authors:  Yi-Chun Tsai; Chi-Chih Hung; Mei-Chuan Kuo; Jer-Chia Tsai; Shih-Meng Yeh; Shang-Jyh Hwang; Yi-Wen Chiu; Hung-Tien Kuo; Jer-Ming Chang; Hung-Chun Chen
Journal:  PLoS One       Date:  2012-12-31       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.